Literature DB >> 30111566

Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.

Jennifer L Welch1, Hussein Kaddour1, Patrick M Schlievert1, Jack T Stapleton1,2,3, Chioma M Okeoma4.   

Abstract

Exosomes play various roles in host responses to cancer and infective agents, and semen exosomes (SE) inhibit HIV-1 infection and transmission, although the mechanism(s) by which this occurs is unclear. Here, we show that SE block HIV-1 proviral transcription at multiple transcriptional checkpoints, including transcription factor recruitment to the long terminal repeat (LTR), transcription initiation, and elongation. Biochemical and functional studies show that SE inhibit HIV-1 LTR-driven viral gene expression and virus replication. Through partitioning of the HIV-1 RNA, we found that SE reduced the optimal expression of various viral RNA species. Chromatin immunoprecipitation-real-time quantitative PCR (ChIP-RT-qPCR) and electrophoretic mobility shift assay (EMSA) analysis of infected cells identified the human transcription factors NF-κB and Sp1, as well as RNA polymerase (Pol) II and the viral protein transcriptional activator (Tat), as targets of SE. Of interest, SE inhibited HIV-1 LTR activation mediated by HIV-1 or Tat, but not by the mitogen phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF-α). SE inhibited the DNA binding activities of NF-κB and Sp1 and blocked the recruitment of these transcription factors and Pol II to the HIV-1 LTR promoter. Importantly, SE directly blocked NF-κB, Sp1, and Pol II binding to the LTR and inhibited the interactions of Tat/NF-κB and Tat/Sp1, suggesting that SE-mediated inhibition of the functional quadripartite complex NF-κB-Sp1-Pol II-Tat may be a novel mechanism of proviral transcription repression. These data provide a novel molecular basis for SE-mediated inhibition of HIV-1 and identify Tat as a potential target of SE.IMPORTANCE HIV is most commonly transmitted sexually, and semen is the primary vector. Despite progress in studies of HIV pathogenesis and the success of combination antiretroviral therapy in controlling viral replication, current therapy cannot completely control sexual transmission. Thus, there is a need to identify effective methods of controlling HIV replication and transmission. Recently, it was shown that human semen contains exosomes that protect against HIV infection in vitro In this study, we identified a mechanism by which semen exosomes inhibited HIV-1 RNA expression. We found that semen exosomes inhibit recruitment of transcription factors NF-κB and Sp1, as well as RNA Pol II, to the promoter region in the 5' long terminal repeat (LTR) of HIV-1. The HIV-1 early protein transcriptional activator (Tat) was a target of semen exosomes, and semen exosomes inhibited the binding and recruitment of Tat to the HIV-1 LTR.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; LTR; NF-κB; RNA Pol II; Sp1; Tat; exosomes; long terminal repeat; promoter; semen; transcription

Mesh:

Substances:

Year:  2018        PMID: 30111566      PMCID: PMC6189507          DOI: 10.1128/JVI.00731-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Translation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells.

Authors:  M Butsch; K Boris-Lawrie
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.

Authors:  F Demarchi; F d'Adda di Fagagna; A Falaschi; M Giacca
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB.

Authors:  P Veschambre; A Roisin; P Jalinot
Journal:  J Gen Virol       Date:  1997-09       Impact factor: 3.891

4.  Interaction of Sp1 transcription factor with HIV-1 Tat protein: looking for cellular partners.

Authors:  Arianna Loregian; Katia Bortolozzo; Silvia Boso; Antonella Caputo; Giorgio Palù
Journal:  FEBS Lett       Date:  2003-05-22       Impact factor: 4.124

5.  Direct interaction of human TFIID with the HIV-1 transactivator tat.

Authors:  F Kashanchi; G Piras; M F Radonovich; J F Duvall; A Fattaey; C M Chiang; R G Roeder; J N Brady
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

6.  Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation.

Authors:  Hye-Sook Kwon; Michael M Brent; Ruth Getachew; Prerana Jayakumar; Lin-Feng Chen; Martina Schnolzer; Michael W McBurney; Ronen Marmorstein; Warner C Greene; Melanie Ott
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

7.  Mechanisms of HIV Transcriptional Regulation and Their Contribution to Latency.

Authors:  Gillian M Schiralli Lester; Andrew J Henderson
Journal:  Mol Biol Int       Date:  2012-06-03

Review 8.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

9.  Nullbasic, a potent anti-HIV tat mutant, induces CRM1-dependent disruption of HIV rev trafficking.

Authors:  Min-Hsuan Lin; Haran Sivakumaran; Ann Apolloni; Ting Wei; David A Jans; David Harrich
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

10.  The HIV-1 Rev protein enhances encapsidation of unspliced and spliced, RRE-containing lentiviral vector RNA.

Authors:  Bastian Grewe; Katrin Ehrhardt; Bianca Hoffmann; Maik Blissenbach; Sabine Brandt; Klaus Uberla
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

View more
  28 in total

Review 1.  The biology, function, and biomedical applications of exosomes.

Authors:  Raghu Kalluri; Valerie S LeBleu
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

2.  Seminal Plasma-Derived Extracellular-Vesicle Fractions from HIV-Infected Men Exhibit Unique MicroRNA Signatures and Induce a Proinflammatory Response in Cells Isolated from the Female Reproductive Tract.

Authors:  Erika G Marques de Menezes; Karen Jang; Ashley F George; Mette Nyegaard; Jason Neidleman; Heather C Inglis; Ali Danesh; Xutao Deng; Amirali Afshari; Young H Kim; Jean-Noël Billaud; Kara Marson; Christopher D Pilcher; Satish K Pillai; Philip J Norris; Nadia R Roan
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

3.  Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment.

Authors:  Folnetti A Alvarez; Hussein Kaddour; Yuan Lyu; Christina Preece; Jules Cohen; Lea Baer; Alison T Stopeck; Patricia Thompson; Chioma M Okeoma
Journal:  Breast Cancer Res Treat       Date:  2022-09-17       Impact factor: 4.624

4.  Semen exosomes inhibit HIV infection and HIV-induced proinflammatory cytokine production independent of the activation state of primary lymphocytes.

Authors:  Jennifer L Welch; Thomas M Kaufman; Jack T Stapleton; Chioma M Okeoma
Journal:  FEBS Lett       Date:  2019-12-02       Impact factor: 4.124

Review 5.  Trophoblastic extracellular vesicles and viruses: Friends or foes?

Authors:  Yingshi Ouyang; Jean-Francois Mouillet; Alexander Sorkin; Yoel Sadovsky
Journal:  Am J Reprod Immunol       Date:  2020-09-27       Impact factor: 3.886

6.  Semen Extracellular Vesicles From HIV-1-Infected Individuals Inhibit HIV-1 Replication In Vitro, and Extracellular Vesicles Carry Antiretroviral Drugs In Vivo.

Authors:  Jennifer L Welch; Hussein Kaddour; Lee Winchester; Courtney V Fletcher; Jack T Stapleton; Chioma M Okeoma
Journal:  J Acquir Immune Defic Syndr       Date:  2020-01-01       Impact factor: 3.771

Review 7.  Shedding Light on the Role of Extracellular Vesicles in HIV Infection and Wound Healing.

Authors:  Aseel Alqatawni; Adhikarimayum Lakhikumar Sharma; Beatrice Attilus; Mudit Tyagi; Rene Daniel
Journal:  Viruses       Date:  2020-05-27       Impact factor: 5.048

Review 8.  The role of exosomal transport of viral agents in persistent HIV pathogenesis.

Authors:  Benjamin J Patters; Santosh Kumar
Journal:  Retrovirology       Date:  2018-12-22       Impact factor: 4.602

Review 9.  Seminal exosomes and HIV-1 transmission.

Authors:  Louise A Ouattara; Sharon M Anderson; Gustavo F Doncel
Journal:  Andrologia       Date:  2018-12       Impact factor: 2.775

10.  Proteomics Profiling of Autologous Blood and Semen Exosomes from HIV-infected and Uninfected Individuals Reveals Compositional and Functional Variabilities.

Authors:  Hussein Kaddour; Yuan Lyu; Jennifer L Welch; Victor Paromov; Sammed N Mandape; Shruti S Sakhare; Jui Pandhare; Jack T Stapleton; Siddharth Pratap; Chandravanu Dash; Chioma M Okeoma
Journal:  Mol Cell Proteomics       Date:  2019-11-01       Impact factor: 7.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.